Consensus Keurig Dr Pepper Inc.

Equities

KDP

US49271V1008

Delayed Nasdaq 04:30:01 2024-03-28 pm EDT 5-day change 1st Jan Change
30.67 USD +0.26% Intraday chart for Keurig Dr Pepper Inc. +3.68% -7.95%

Evolution of the average Target Price on Keurig Dr Pepper Inc.

Price target over the last 5 years

History of analyst recommendation changes

1.gBmKujqdxSlnUc1L-0sgFPcBHIlG-iFb6ANLbleFD48.wUHJ9mXNrkAMJaJ5kAFSQLtUKMsSoEhukUkdGT_nS-6xVtrKc8WaRBI19Q~56aec03895cb119661bd93eb32223e48
Jefferies Cuts Keurig Dr Pepper's Price Target to $35 From $37, Keeps Buy Rating MT
Barclays Cuts Price Target on Keurig Dr Pepper to $32 From $34, Keeps Overweight Rating MT
ANALYST RECOMMENDATIONS : Block, Estee Lauder, Dell, Netflix, Nvidia... Our Logo
Morgan Stanley Cuts Price Target on Keurig Dr Pepper to $34 From $37, Keeps Equalweight Rating MT
Wedbush Lowers Keurig Dr Pepper's PT to $35 From $37 After Mixed Q4 2023 Results, Maintains Outperform Rating MT
Barclays Cuts Price Target on Keurig Dr Pepper to $34 From $37, Maintains Overweight Rating MT
Deutsche Bank Trims Keurig Dr Pepper Price Target to $33 From $34, Maintains Hold Rating MT
RBC Trims Price Target on Keurig Dr Pepper to $41 From $42, Keeps Outperform Rating MT
UBS Cuts Price Target on Keurig Dr Pepper to $36 From $38, Maintains Buy Rating MT
UBS Adjusts Keurig Dr Pepper Price Target to $38 From $37, Maintains Buy Rating MT
Morgan Stanley Downgrades Keurig Dr Pepper to Equalweight From Overweight, Price Target is $37 MT
Analyst recommendations: Blackstone, Citigroup, Icon, Amazon, Broadcom... Our Logo
Big tech saves the day Our Logo
ANALYST RECOMMENDATIONS : Airbnb, Apple, Best Buy, Diageo, Tesla... Our Logo
Barclays Raises Price Target on Keurig Dr Pepper to $36 From $34, Maintains Overweight Rating MT
UBS Cuts Keurig Dr Pepper Price Target to $37 From $39, Maintains Buy Rating MT
Morgan Stanley Cuts Price Target on Keurig Dr Pepper to $37 From $39, Maintains Overweight Rating MT
Deutsche Bank Trims Keurig Dr Pepper Price Target to $34 From $35, Maintains Hold Rating MT
Bernstein Adjusts Keurig Dr Pepper Price Target to $37 From $40, Maintains Outperform Rating MT
Citigroup Adjusts Price Target on Keurig Dr Pepper to $33 From $37, Maintains Neutral Rating MT
UBS Cuts Keurig Dr Pepper Price Target to $39 From $42, Maintains Buy Rating MT
All options are on the table Our Logo
ANALYST RECOMMENDATIONS : Apple, Progressive, Mondelez, Pepsico... Our Logo
UBS Upgrades Keurig Dr Pepper to Buy From Neutral, Adjusts Price Target to $42 From $37 MT
Wedbush Raises Keurig Dr Pepper's Price Target to $40 From $37 After Higher-Than-Expected Q2 Results, Keeps Outperform Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
30.67 USD
Average target price
34.56 USD
Spread / Average Target
+12.68%
High Price Target
41 USD
Spread / Highest target
+33.68%
Low Price Target
27 USD
Spread / Lowest Target
-11.97%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Keurig Dr Pepper Inc.

Jefferies & Co.
Barclays
Morgan Stanley
Wedbush
Deutsche Bank Securities
RBC Capital Markets
UBS
Bernstein
Citigroup
Goldman Sachs
JPMorgan Chase
Credit Suisse
Wells Fargo Securities
Truist Securities
Consumer Edge
Guggenheim
Cowen
J.P. Morgan Chase
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings